لا يوجد علاج دوائي شافي للارتجاف الاذيني الا انه وبحسب دراسة مخبرية (لم تختبر بعد سريرياً) وجدت ان لدواء المنظم للسكر ميتفورمين خصائص مخبرية قد تمنع الاصابة بالارتجاف وتعالج منه . https://t.co/CYn0B13k7b
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2022 – Jun 2023Where it's discussed
-
News24 articles
-
X / Twitter17 posts
-
Blogs4 articles
-
Facebook2 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions demonstrate high enthusiasm and detailed engagement, with many posters stating the significance of using network medicine to identify repurposable drugs like metformin for atrial fibrillation, reflecting the perceived high impact of these findings on medical practice and research.
Most discussions express strong support and recognition of the research findings, notably emphasizing the potential of metformin for atrial fibrillation.
Posters display high interest, frequently highlighting the innovative approach and potential clinical implications, using words like 'significantly', 'predicts', and 'identify'.
Many comments reference specific methodologies and implications, such as network analysis and drug repurposing, showing deep engagement with the content.
The overall tone suggests a belief that this research could have a meaningful impact on treatment strategies and future studies, as seen in phrases like 'potential to transform' and 'significant reduction in risk'.
Top posts
Most liked on X and BlueskyOnline now: Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/pZeRVuc7Tt
"Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation" @HealthyFellow @dlifein https://t.co/ENmXc8JAbw https://t.co/sd2egp8h9Y
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/VJodbKOUKT
El uso de #metformina se asocia significativamente con reducción en el riesgo de Fibrilación Auricular, al compararse con tratamientos estándar para diabetes.
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/juA89JNwau
All mentions
Metformin as a Potential Drug for Atrial Fibrillation Identified by Network Analysis
On May 2, 2023, the NUPPEESI seminar discussed a study that used transcriptomics-based network medicine to identify metformin as a repurposable drug for atrial fibrillation, highlighting innovative approaches in…
RT @CellRepMed: Online now: Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrilla…
@arunkumar3112 Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation Network proximity analysis predicts metformin as repurposed drug for AF➡️Metformin induces directional changes in AF disease module genes. https://t.co/Ygtu11f3QI
RT @CardioCaribeMx: El uso de #metformina se asocia significativamente con reducción en el riesgo de Fibrilación Auricular, al compararse c…
El uso de #metformina se asocia significativamente con reducción en el riesgo de Fibrilación Auricular, al compararse con tratamientos estándar para diabetes.
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation: Cell Reports Medicine https://t.co/wemA8pY1RR
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/juA89JNwau
RT @CellRepMed: Online now: Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrilla…
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/GxpfwXH4d1
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/Rw8EoeTm6D
RT @CellRepMed: Online now: Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrilla…
Online now: Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/pZeRVuc7Tt
RT @DRKAMALAYOUB: لا يوجد علاج دوائي شافي للارتجاف الاذيني الا انه وبحسب دراسة مخبرية (لم تختبر بعد سريرياً) وجدت ان لدواء المنظم للسكر مي…
لا يوجد علاج دوائي شافي للارتجاف الاذيني الا انه وبحسب دراسة مخبرية (لم تختبر بعد سريرياً) وجدت ان لدواء المنظم للسكر ميتفورمين خصائص مخبرية قد تمنع الاصابة بالارتجاف وتعالج منه . https://t.co/CYn0B13k7b
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/VJodbKOUKT
RT @shashiiyengar: "Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation" @…
RT @shashiiyengar: "Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation" @…
"Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation" @HealthyFellow @dlifein https://t.co/ENmXc8JAbw https://t.co/sd2egp8h9Y